PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-09-27
DOI
10.1111/jcmm.14586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy
- (2018) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection
- (2018) Susana Cadenas FREE RADICAL BIOLOGY AND MEDICINE
- PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDL-Cholesterol
- (2018) Zhao-Peng Liu et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction
- (2016) Savitree Thummasorn et al. Cardiovascular Therapeutics
- Relationship Between Infarct Size and Outcomes Following Primary PCI
- (2016) Gregg W. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
- (2015) Miguel Cainzos-Achirica et al. ANNALS OF INTERNAL MEDICINE
- Update of Clinical Trials of Anti-PCSK9 Antibodies
- (2015) Na-Qiong Wu et al. CARDIOVASCULAR DRUGS AND THERAPY
- Cross-talk between LOX-1 and PCSK9 in vascular tissues
- (2015) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Systematic review/Meta-analysis The incidence of acute myocardial infarction in relation to overweight and obesity: a meta-analysis
- (2014) Jun Zhu et al. Archives of Medical Science
- Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner
- (2014) Mei Cui et al. MOLECULAR NEUROBIOLOGY
- Combined Vildagliptin and Metformin Exert Better Cardioprotection than Monotherapy against Ischemia-Reperfusion Injury in Obese-Insulin Resistant Rats
- (2014) Nattayaporn Apaijai et al. PLoS One
- Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission
- (2013) Willard W. Sharp et al. FASEB JOURNAL
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias
- (2013) Michael J. Curtis et al. PHARMACOLOGY & THERAPEUTICS
- Acute Inhibition of Excessive Mitochondrial Fission After Myocardial Infarction Prevents Long‐term Cardiac Dysfunction
- (2013) Marie‐Hélène Disatnik et al. Journal of the American Heart Association
- Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease
- (2012) Tetsuya Tobaru et al. HEART AND VESSELS
- Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury
- (2010) Sang-Bing Ong et al. CIRCULATION
- Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis
- (2009) G. Dewson et al. JOURNAL OF CELL SCIENCE
- Comparison of cumulative planimetry versus manual dissection to assess experimental infarct size in isolated hearts
- (2009) Matthias L. Riess et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Plasma PCSK9 preferentially reduces liver LDL receptors in mice
- (2008) Aldo Grefhorst et al. JOURNAL OF LIPID RESEARCH
- PCSK9: a convertase that coordinates LDL catabolism
- (2008) Jay D. Horton et al. JOURNAL OF LIPID RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started